Recombinant human endostatin (rh-endostatin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human endostatin (rh-endostatin), covering 2017-07-05 to 2017-07-05. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC) [Phase 2]